FDA批准-话题@MedSci

#FDA批准#

870篇内容 | 7881人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1839516, encodeId=23681839516a9, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, objectTitle=FDA批准检测白血病和淋巴瘤的试剂上市, objectType=article, longId=104185, objectId=c73010418568, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c73010418568, replyNumber=0, likeNumber=92, createdTime=2017-08-27, rootId=0, userName=bugit, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c73010418568, moduleTitle=FDA批准检测白血病和淋巴瘤的试剂上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c73010418568)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1839548, encodeId=6b341839548b9, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, objectTitle=**双药HIV疗法今日获美国FDA批准, objectType=article, longId=121083, objectId=dc9912108308, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dc9912108308, replyNumber=0, likeNumber=98, createdTime=2017-11-22, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dc9912108308, moduleTitle=**双药HIV疗法今日获美国FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dc9912108308)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1839562, encodeId=053f1839562ac, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, objectTitle=Nat Commun：FDA批准的高血压药物能延缓神经退行性病变, objectType=article, longId=124326, objectId=173612432615, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=173612432615, replyNumber=0, likeNumber=62, createdTime=2018-11-03, rootId=0, userName=bugit, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=173612432615, moduleTitle=Nat Commun：FDA批准的高血压药物能延缓神经退行性病变, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=173612432615)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1839507, encodeId=473a183950eee, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, objectTitle=2017年FDA批准新药名单，上半年已达21种！, objectType=article, longId=99723, objectId=7b0299e238b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b0299e238b, replyNumber=0, likeNumber=59, createdTime=2017-12-17, rootId=0, userName=bugit, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b0299e238b, moduleTitle=2017年FDA批准新药名单，上半年已达21种！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b0299e238b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1839522, encodeId=a1281839522d2, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, objectTitle=FDA批准了20年来镰刀型细胞贫血病新药, objectType=article, longId=107448, objectId=90a510e448e0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90a510e448e0, replyNumber=0, likeNumber=43, createdTime=2017-09-15, rootId=0, userName=bugit, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90a510e448e0, moduleTitle=FDA批准了20年来镰刀型细胞贫血病新药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90a510e448e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1839543, encodeId=b74f183954395, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, objectTitle=伊布替尼适应症再次扩大：FDA批准伊布替尼成治疗慢性移植物抗宿主病（cGVHD）的药物, objectType=article, longId=116550, objectId=0a20116550c3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a20116550c3, replyNumber=0, likeNumber=58, createdTime=2018-07-01, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a20116550c3, moduleTitle=伊布替尼适应症再次扩大：FDA批准伊布替尼成治疗慢性移植物抗宿主病（cGVHD）的药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a20116550c3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1839527, encodeId=7205183952eb6, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, objectTitle=老树开新花！金刚烷胺新用途获FDA批准, objectType=article, longId=111183, objectId=4d34111183a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d34111183a5, replyNumber=0, likeNumber=118, createdTime=2018-01-13, rootId=0, userName=bugit, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d34111183a5, moduleTitle=老树开新花！金刚烷胺新用途获FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d34111183a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1839508, encodeId=c47018395080a, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, objectTitle=FDA批准一项个性化免疫治疗的癌症药物, objectType=article, longId=100011, objectId=f0c2100011c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f0c2100011c2, replyNumber=0, likeNumber=55, createdTime=2018-01-30, rootId=0, userName=bugit, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f0c2100011c2, moduleTitle=FDA批准一项个性化免疫治疗的癌症药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f0c2100011c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1839571, encodeId=6c3b18395e110, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, objectTitle=FDA批准阿法替尼治疗罕见肺癌, objectType=article, longId=126688, objectId=f23e126688e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f23e126688e5, replyNumber=0, likeNumber=81, createdTime=2018-01-24, rootId=0, userName=bugit, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f23e126688e5, moduleTitle=FDA批准阿法替尼治疗罕见肺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f23e126688e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1839569, encodeId=21131839569d9, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, objectTitle=Lancet Oncol：重磅，乳腺癌的救星：FDA批准与乳腺癌基因相关的肿瘤药物！, objectType=article, longId=126475, objectId=5f411264e592, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f411264e592, replyNumber=0, likeNumber=73, createdTime=2018-07-07, rootId=0, userName=bugit, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f411264e592, moduleTitle=Lancet Oncol：重磅，乳腺癌的救星：FDA批准与乳腺癌基因相关的肿瘤药物！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f411264e592)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1839497, encodeId=605f183949e7c, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, objectTitle=Ann Intern Med：FDA批准的口服DAA药物有很高的HCV治愈率, objectType=article, longId=92953, objectId=c41492953b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c41492953b7, replyNumber=0, likeNumber=77, createdTime=2017-11-07, rootId=0, userName=bugit, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c41492953b7, moduleTitle=Ann Intern Med：FDA批准的口服DAA药物有很高的HCV治愈率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c41492953b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1839545, encodeId=318f18395459a, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, objectTitle=FDA批准**一款治疗非透析慢性肾病患者缺铁性贫血片剂, objectType=article, longId=119295, objectId=3b6d1192950b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b6d1192950b, replyNumber=0, likeNumber=60, createdTime=2017-12-17, rootId=0, userName=仁医06, userId=55683, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b6d1192950b, moduleTitle=FDA批准**一款治疗非透析慢性肾病患者缺铁性贫血片剂, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3b6d1192950b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1839524, encodeId=9a93183952449, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, objectTitle=Kite多发性骨髓瘤CAR-T疗法获美FDA批准, objectType=article, longId=108224, objectId=e2a810822478, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e2a810822478, replyNumber=0, likeNumber=81, createdTime=2018-05-04, rootId=0, userName=bugit, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e2a810822478, moduleTitle=Kite多发性骨髓瘤CAR-T疗法获美FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e2a810822478)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1839529, encodeId=02371839529af, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, objectTitle=FDA批准美国恰加斯病治疗药物, objectType=article, longId=111429, objectId=1286111429a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1286111429a2, replyNumber=0, likeNumber=85, createdTime=2018-06-26, rootId=0, userName=bugit, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1286111429a2, moduleTitle=FDA批准美国恰加斯病治疗药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1286111429a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1839563, encodeId=b21f1839563ec, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, objectTitle=Nat Commun：研究发现FDA批准的这种降压药还能延长寿命！, objectType=article, longId=124333, objectId=5f9d1243336c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f9d1243336c, replyNumber=0, likeNumber=77, createdTime=2018-10-04, rootId=0, userName=bugit, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f9d1243336c, moduleTitle=Nat Commun：研究发现FDA批准的这种降压药还能延长寿命！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f9d1243336c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1839500, encodeId=e0b7183950095, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, objectTitle=FDA批准治疗罕见皮肤癌药物, objectType=article, longId=93312, objectId=e31d93312a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e31d93312a0, replyNumber=0, likeNumber=78, createdTime=2017-07-21, rootId=0, userName=bugit, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e31d93312a0, moduleTitle=FDA批准治疗罕见皮肤癌药物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e31d93312a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1839568, encodeId=706b183956801, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, objectTitle=全球针对肝癌的PD-1抗体获FDA批准，奋起直追，国产PD-1抗体顺利进入三期临床, objectType=article, longId=125937, objectId=16d012593e87, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16d012593e87, replyNumber=0, likeNumber=69, createdTime=2018-01-14, rootId=0, userName=bugit, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16d012593e87, moduleTitle=全球针对肝癌的PD-1抗体获FDA批准，奋起直追，国产PD-1抗体顺利进入三期临床, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16d012593e87)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1839515, encodeId=aed3183951568, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, objectTitle=2017上半年FDA批准的新药, objectType=article, longId=103774, objectId=789a103e7459, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=789a103e7459, replyNumber=0, likeNumber=55, createdTime=2017-11-08, rootId=0, userName=bugit, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=789a103e7459, moduleTitle=2017上半年FDA批准的新药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=789a103e7459)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1839498, encodeId=06ad183949851, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, objectTitle=又有39个医疗器械获CFDA批准上市, objectType=article, longId=92996, objectId=e5e59299619, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5e59299619, replyNumber=0, likeNumber=61, createdTime=2018-03-02, rootId=0, userName=bugit, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5e59299619, moduleTitle=又有39个医疗器械获CFDA批准上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5e59299619)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1839499, encodeId=cc90183949990, content=<a href='/topic/show?id=341ae311ea' target=_blank style='color:#2F92EE;'>#FDA批准#</a>, objectTitle=罗氏黑色素瘤新药「维莫非尼」获CFDA批准上市, objectType=article, longId=93141, objectId=ee2c931418a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee2c931418a, replyNumber=0, likeNumber=53, createdTime=2017-12-10, rootId=0, userName=bugit, userId=30bd35, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee2c931418a, moduleTitle=罗氏黑色素瘤新药「维莫非尼」获CFDA批准上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee2c931418a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

FDA批准

2020-05-29发表于威斯康星

bugit (审核中...)

前往app查看评论内容

#FDA批准#

FDA批准检测白血病和淋巴瘤的试剂上市

2017-08-27

仁医06 (审核中...)

前往app查看评论内容

#FDA批准#

**双药HIV疗法今日获美国FDA批准

2017-11-22

bugit (审核中...)

前往app查看评论内容

#FDA批准#

Nat Commun：FDA批准的高血压药物能延缓神经退行性病变

2018-11-03

bugit (审核中...)

前往app查看评论内容

#FDA批准#

2017年FDA批准新药名单，上半年已达21种！

2017-12-17

bugit (审核中...)

前往app查看评论内容

#FDA批准#

FDA批准了20年来镰刀型细胞贫血病新药

2017-09-15

仁医06 (审核中...)

前往app查看评论内容

#FDA批准#

伊布替尼适应症再次扩大：FDA批准伊布替尼成治疗慢性移植物抗宿主病（cGVHD）的药物

2018-07-01

bugit (审核中...)

前往app查看评论内容

#FDA批准#

老树开新花！金刚烷胺新用途获FDA批准

2018-01-13

bugit (审核中...)

前往app查看评论内容

#FDA批准#

FDA批准一项个性化免疫治疗的癌症药物

2018-01-30

bugit (审核中...)

前往app查看评论内容

#FDA批准#

FDA批准阿法替尼治疗罕见肺癌

2018-01-24

bugit (审核中...)

前往app查看评论内容

#FDA批准#

Lancet Oncol：重磅，乳腺癌的救星：FDA批准与乳腺癌基因相关的肿瘤药物！

2018-07-07

bugit (审核中...)

前往app查看评论内容

#FDA批准#

Ann Intern Med：FDA批准的口服DAA药物有很高的HCV治愈率

2017-11-07

仁医06 (审核中...)

前往app查看评论内容

#FDA批准#

FDA批准**一款治疗非透析慢性肾病患者缺铁性贫血片剂

2017-12-17

bugit (审核中...)

前往app查看评论内容

#FDA批准#

Kite多发性骨髓瘤CAR-T疗法获美FDA批准

2018-05-04

bugit (审核中...)

前往app查看评论内容

#FDA批准#

FDA批准美国恰加斯病治疗药物

2018-06-26

bugit (审核中...)

前往app查看评论内容

#FDA批准#

Nat Commun：研究发现FDA批准的这种降压药还能延长寿命！

2018-10-04

bugit (审核中...)

前往app查看评论内容

#FDA批准#

FDA批准治疗罕见皮肤癌药物

2017-07-21

bugit (审核中...)

前往app查看评论内容

#FDA批准#

全球针对肝癌的PD-1抗体获FDA批准，奋起直追，国产PD-1抗体顺利进入三期临床

2018-01-14

bugit (审核中...)

前往app查看评论内容

#FDA批准#

2017上半年FDA批准的新药

2017-11-08

bugit (审核中...)

前往app查看评论内容

#FDA批准#

又有39个医疗器械获CFDA批准上市

2018-03-02

bugit (审核中...)

前往app查看评论内容

#FDA批准#

罗氏黑色素瘤新药「维莫非尼」获CFDA批准上市

2017-12-10

科室
- - 订阅+
  - 更多科室
工具
服务